ArticleIn silico pharmacology2025
Zebrafish and bioactive compounds: a bibliometric review.
Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bibliometrics has become a crucial tool for evaluating and analyzing researchers' output. In recent decades, zebrafish has demonstrated its potential for studying oxidative stress, and the use of medicinal plants has proven essential in this context, as they are endowed with bioactive compounds that possess antioxidant properties. Thus, the aim of this study was to conduct a bibliometric review to analyze the evolution of publications concerning the concepts of "zebrafish" and "bioactive compounds." The Web of Science (WoS) database was utilized. Data on authors, countries, most cited journals, co-authorship between countries and authors, co-occurrence of keywords, keyword co-occurrence by publication year, and co-citation of references were analyzed using VOSviewer software. A total of 170 documents were retrieved, spanning the years 2004 to 2024. Jean Luc Wolfender, the United States, and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.